Clinicopathological factors and prognosis analysis of 39 cases of non-gestational ovarian choriocarcinoma
Autor: | Yanhui Ma, Xiaolei Zhang, Xiaodie Liu, Yingxin Pang, Peishu Liu, Xue Zhang |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Gestational Ovarian Choriocarcinoma Adolescent Cochrane Library Metastasis Ovarian Choriocarcinoma Young Adult 03 medical and health sciences 0302 clinical medicine Pregnancy Internal medicine Humans Medicine Choriocarcinoma Stage (cooking) Child Aged Ovarian Neoplasms Univariate analysis 030219 obstetrics & reproductive medicine business.industry Incidence (epidemiology) Obstetrics and Gynecology General Medicine Middle Aged Neoplasms Germ Cell and Embryonal Prognosis medicine.disease Chemotherapy regimen 030220 oncology & carcinogenesis Female business |
Zdroj: | Archives of Gynecology and Obstetrics. 301:901-912 |
ISSN: | 1432-0711 0932-0067 |
DOI: | 10.1007/s00404-020-05502-9 |
Popis: | Non-gestational ovarian choriocarcinoma (NGOC) is a rare malignant germ cell tumor. Through literature review and cases collection, we aim to analyze prognostic factors for NGOC and summarize its clinicopathological characteristics to guide the individualized treatment. We searched PubMed database, Cochrane library, and Google Scholar for cases published between January 1, 1967 and July 31, 2018 using various search terms. We retrieved patients’ clinicopathological characteristics, treatment, and prognosis information from included studies. These patients were divided into two groups: died (case group) or alive (control group) group. We summarized and compared their clinical (age, symptoms, R0 resection, serum HCG levels, chemotherapy regimen) and pathological (pure vs non-pure type, tumor size, tumor location, metastasis sites, stage) features by statistical analysis. Only 39 patients were retrieved from 36 studies in total. The median age was 30 years (range 12- to 65-years old). The peak incidence was in the adolescent age 12–25 years. Median follow-up was 20.3 months (range 1–84 months). 9 (23%) patients died; 24 (62%) patients were alive; 6 (15%) were lost to follow-up. Upon univariate analysis, we found age had a poor impact on overall survival (OS) in NGOC, HR − 0.057, 95% CI − 0.111 to − 0.004. Pure type NGOC has a better OS than mixed type, HR − 2.621, 95% CI − 4.577 to − 0.666. R0 resection is a good prognostic factor for OS, HR 2.967, 95% CI 0.709–5.224. Clinicians should try to achieve R0 resection to improve the prognosis for NGOC patients even among advanced patients. |
Databáze: | OpenAIRE |
Externí odkaz: |